載入...
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development
Reduction of native prion protein (PrP) levels in the brain is an attractive strategy for the treatment or prevention of human prion disease. Clinical development of any PrP-reducing therapeutic will require an appropriate pharmacodynamic biomarker: a practical and robust method for quantifying PrP,...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475435/ https://ncbi.nlm.nih.gov/pubmed/30936307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1901947116 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|